Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 925 | 1105 | 893 | 498 | 1005 | - |
Fund Return | -7.46% | 10.51% | -10.7% | -20.75% | 0.1% | - |
Place in category | 54 | 250 | 46 | 136 | 34 | - |
% in Category | 21 | 88 | 19 | 88 | 55 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF Stable Growth Mixed Assets Fund | 13.8B | -0.14 | -3.66 | 9.31 | ||
GF NASDAQ 100 Index Fund QDIII | 12.49B | 24.33 | 11.59 | 17.94 | ||
GF Tech Pioneer Alloc | 9.98B | 16.34 | -17.30 | - | ||
GF Global Selction Eq QDII | 8.35B | 24.67 | 4.02 | 12.82 | ||
GF Small-Cap Growth Stock Fd(LOF) | 6.67B | 3.15 | -16.94 | 7.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS QY Medical Eq | 12.06B | -9.87 | -15.34 | - | ||
CMF CNI Bio Health Index | 11.05B | -18.05 | -24.29 | - | ||
Hwabao WP CSI Medical Index | 6.98B | -11.88 | -20.60 | - | ||
China Universal Healthcare Serv mix | 3.44B | 2.37 | -16.42 | - | ||
Penghua Medical Tech Eq | 3.31B | -5.56 | -3.34 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 8.22 | 196.63 | -1.44% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 4.74 | 50.41 | -3.08% | |
Kelun Pharm A | CNE100000PW7 | 4.58 | 30.43 | -0.26% | |
Jiangsu Hengrui | CNE0000014W7 | 4.08 | 46.25 | -0.62% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 3.51 | 62.24 | +0.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Sell |
Technical Indicators | Strong Sell | Sell | Strong Sell |
Summary | Strong Sell | Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review